In this study, the tRF-T36 mimic effectively targeted and downregulated NUCKS1, a molecule in the PI3K-Akt pathway [39], resulting in successful suppression of CRC progression even at low dosages. The gene discussed is AKT1; the disease is colorectal carcinoma.